Retatrutide has emerged as one of the most discussed investigational therapies for obesity in recent times. Though this drug is yet to be cleared for regular use, there has been a tremendous amount of buzz about this drug due to the outstanding findings from a ground-breaking phase 2 clinical trial that was published in The New England Journal of Medicine (NEJM).
Read More
Retatrutide is one of the most highly anticipated experimental drugs within the domain of obesity and metabolic diseases.
Read More
